Congenital toxoplasmosis

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue SUPPL1, 2014, Pages

  McAuley, James B ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Infant; Toxoplasmosis; Transmission

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; FOLINIC ACID; IMMUNOGLOBULIN M; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ARTICLE; BINDING AFFINITY; BRADYZOITE; CAT; CONGENITAL INFECTION; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; FOOD FREEZING; FOOD POISONING; FOOD SAFETY; HUMAN; NONHUMAN; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; RAW MEAT; RISK FACTOR; TACHYZOITE; TOXOPLASMA GONDII; VERTICAL TRANSMISSION; VIRUS INFECTIVITY;

EID: 84922465561     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu077     Document Type: Article

References (23)

1. McAuley JB, Jones JL, Singh K. Toxoplasma. In Manual of Clinical Microbiology. 11th ed. Washington DC: ASM Press; 2014.
2. Centers for Disease Control and Prevention. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000; 49(RR-2): 57-75.
3. Munoz-Zanzi CA, Fry P, Lesina B, Hill D. Toxoplasma gondii oocyst-specific antibodies and source of infection. Emerg Infect Dis 2010; 16:1591-5.
4. Lindsay DS, Dubey JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 2011; 138:1829-31.
5. Robbins JR, Zeldovich VB, Poukchanski A, et al. Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun 2011; 80:418-28.
6. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for Toxoplasmosis. Clin Microbiol Rev 2012; 25: 264-96.
7. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg 2007; 77: 405-10.
8. Kusbeci OY, Miman O, Yaman M, et al. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 2011; 25:1-3.
9. Ling VJ, Lester D, Mortensen PB, et al. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011; 199: 440-4.
10. Arias I, Sorlozano A, Villegas E, et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res 2012; 136: 128-36.
11. Siberry GK, Abzug MJ, Nachman S, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J 2013; 32 (Suppl 2):i-KK4.
12. Schmidt-Hieber M, Zweigner J, Uharek L, et al. Central nervous system infections in immunocompromised patients - update on diagnosis and therapy. Leuk Lymphoma 2009; 50:24-36.
13. Jones J, Holland GN. Short report: annual burden of ocular toxoplasmosis in the United States.AmJ Trop MedHyg 2010; 82:464-5.
14. Boyer KM, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 2005; 192:564-71.
15. Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49:878-84.
16. Jones JL, Lopez A, Wilson M, et al. Congenital toxoplasmosis: a review. Obstet Gynecol Surv 2001; 56:296-305.
17. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: TheW. B. Saunders Co.; 2006: pp 947-1092.
18. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76.
19. Robert-Gangneux F, Gavinet MF, Ancelle T, et al. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 1999; 37:2893-8.
20. Gilbert R, Dunn D, Wallon M, et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect 2001; 127: 113-20.
21. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318:271-5.
22. Stillwaggon E, Carrier CS, SautterM,McLeodR.Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011; 5:e1333.
23. McCabe R, Remington JS. Toxoplasmosis: the time has come. 1988; N Engl J Med 318:313-5.